Private Advisor Group, LLC Mannkind Corp Transaction History

Private Advisor Group, LLC

$18.8 Billion
Q3 2025

A detailed history of Private Advisor Group, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Private Advisor Group, LLC holds 19,726 shares of MNKD stock, worth $99,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,726

Previous 29,766 33.73%

Holding current value

$99,813

Previous $111,000 5.41%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$3.42 - $5.74 $34,336 - $57,629	-10,040 Reduced 33.73%	19,726 $105,000
Q2 2025 Aug 11, 2025	SELL	$3.71 - $5.04 $1,335 - $1,814	-360 Reduced 1.19%	29,766 $111,000
Q1 2025 May 05, 2025	SELL	$4.92 - $6.6 $2,095 - $2,811	-426 Reduced 1.39%	30,126 $151,000
Q4 2024 Jan 31, 2025	SELL	$5.93 - $7.44 $195 - $245	-33 Reduced 0.11%	30,552 $196,000
Q3 2024 Oct 22, 2024	BUY	$5.01 - $6.7 $48,035 - $64,239	9,588 Added 45.66%	30,585 $192,000

Q2 2024 Aug 05, 2024	SELL	$4.05 - $5.43 $7,371 - $9,882	-1,820 Reduced 7.98%	20,997 $109,000
Q1 2024 Apr 30, 2024	SELL	$3.25 - $5.27 $4,576 - $7,420	-1,408 Reduced 5.81%	22,817 $103,000
Q4 2023 Feb 06, 2024	SELL	$3.34 - $4.29 $5,156 - $6,623	-1,544 Reduced 5.99%	24,225 $88,000
Q3 2023 Nov 02, 2023	SELL	$3.91 - $5.45 $4,480 - $6,245	-1,146 Reduced 4.26%	25,769 $106,000
Q2 2023 Aug 09, 2023	SELL	$3.72 - $4.79 $10,438 - $13,440	-2,806 Reduced 9.44%	26,915 $109,000
Q1 2023 May 10, 2023	BUY	$3.95 - $5.63 $13,880 - $19,783	3,514 Added 13.41%	29,721 $121,000
Q3 2022 Oct 14, 2022	SELL	$2.99 - $4.35 $2,392 - $3,479	-800 Reduced 2.96%	26,207 $81,000
Q2 2022 Jul 13, 2022	SELL	$2.67 - $4.77 $6,675 - $11,924	-2,500 Reduced 8.47%	27,007 $103,000
Q1 2022 May 12, 2022	SELL	$2.62 - $4.45 $2,758 - $4,685	-1,053 Reduced 3.45%	29,507 $109,000
Q4 2021 Feb 10, 2022	BUY	$4.05 - $5.37 $82,976 - $110,020	20,488 Added 203.42%	30,560 $134,000
Q3 2021 Oct 14, 2021	BUY	$3.89 - $5.48 $39,180 - $55,194	10,072 New	10,072 $44,000
Q3 2020 Nov 02, 2020	SELL	$1.56 - $2.08 $11,099 - $14,799	-7,115 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.94 - $2.21 $6,688 - $15,724	7,115 New	7,115 $12,000
Q4 2018 Feb 11, 2019	SELL	$1.02 - $2.05 $12,921 - $25,969	-12,668 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$1.01 - $2.19 $12,794 - $27,742	12,668 New	12,668 $23,000
Q2 2018 Aug 09, 2018	SELL	$1.59 - $2.38 $22,837 - $34,183	-14,363 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$2.28 - $3.8 $32,747 - $54,579	14,363 New	14,363 $33,000
Q4 2017 Feb 07, 2018	SELL	$2.28 - $6.71 $89,382 - $263,052	-39,203 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$1.15 - $2.29 $6,589 - $13,121	-5,730 Reduced 12.75%	39,203 $203,000
Q2 2017 Aug 10, 2017	BUY	N/A	44,933	44,933 $53,000

Others Institutions Holding MNKD

# of Institutions

257

Shares Held

165M

Call Options Held

2.76M

Put Options Held

689K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.3B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Mannkind Corp Transaction History